Roze AI Inc. (RZAI) registered 18,138,565 common shares for resale by existing shareholders in connection with a proposed Nasdaq direct listing, including 13,878,565 outstanding shares and 4,260,000 shares issuable upon warrant exercise. Roze AI says it will receive no proceeds from shareholder resales.
Separately, Roze AI agreed to sell 1,250,000 Class C preferred shares for gross proceeds of $10,000,000 at $8.00 per share before the prospectus date. Each has a $10.00 stated value. The conversion price is the lower of $8.00 or 80% of the lowest closing sale price over the five consecutive trading days immediately before conversion; the floor starts at $4.00 and is subject to downward adjustment to $1.00 no later than 120 days after initial issuance. These preferred shares and underlying common shares are not registered here. Nasdaq approval is a condition to the direct listing.
Revenue was $2,295,237 in 2025 versus $8,225,475 in 2024, and net loss was $6,030,257 versus $1,444,257. Roze AI attributed the revenue decline mainly to deferred timing of large projects and disclosed substantial doubt about its ability to continue as a going concern, citing reliance on financing and future profitable operations.